肋骨部分切除肋膈角闭合术在肝脏肿瘤高强度聚焦超声治疗中的应用  

Application of partial costectomy and costophrenic angle closure to supplement high intensity focused ultrasound treatment for liver tumor

作　　者：秦海峰[1] 黄乃祥[1] 汪伟[1] 罗明玉[1] 

机构地区：[1]军事医学科学院附属医院胸外科,北京100039

出　　处：《中华肿瘤杂志》2005年第5期316-318,共3页Chinese Journal of Oncology

摘　　要：目的探讨肋骨部分切除、肋膈角闭合术(PCCAC)在肝脏肿瘤治疗中应用的手术方法及围手术期处理的新特点。方法回顾性分析同期为采用高强度聚焦超声(HIFU)治疗而行PCCAC的肝脏肿瘤患者的临床资料。结果69例行PCCAC手术的肝脏肿瘤患者中,有术前并发症的92.8%,出现术后并发症的13.0%,手术死亡率为0;手术前后肝、肾功能及肺功能改变不显著(P>0.05)。结论PCCAC作为HIFU治疗肝脏肿瘤的一种新的辅助治疗手段,手术创伤小、并发症少、安全性高,不会对患者的呼吸生理造成不良影响,具有应用前景。Objective To investigate the application of partial costectomy and costophrenic angle closure (PCCAC) and perioperative management in the treatment of liver tumor by high intensity focused ultrasound (HIFU). Methods The clinical data of 69 patients with liver tumor underwent HIFU within the recent four years were retrospectively reviewed. Results 92.8% of these 69 liver tumor patients had had concomitant diseases and 13.0% of them developed postoperative complications without anyone died. There was no significant postoperative dysfunctions of kidney or lung as compaired with the preoperative ones (P>0.05). Conclusion In the treatment of liver tumor by HIFU, PCCAC,as an auxillary means, giving few complications and little harmful effects on respiratory physiology, is highly safe.

关 键 词：肋骨部分切除 肋膈角闭合术 肝脏肿瘤 超声治疗 

分 类 号：R735.7[医药卫生—肿瘤]